1. SARS-CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10.
- Author
-
Gomes AMC, Farias GB, Dias-Silva M, Laia J, Trombetta AC, Godinho-Santos A, Rosmaninho P, Santos DF, Conceição CM, Costa-Reis R, Adão-Serrano M, Mota C, Almeida ARM, Sousa AE, and Fernandes SM
- Subjects
- Adult, Aged, Antigens, Neoplasm metabolism, Cell Proliferation, Cytokines metabolism, Female, Humans, Immunity, Innate, Male, Middle Aged, Mitogen-Activated Protein Kinases metabolism, Recovery of Function, Th2 Cells immunology, Up-Regulation, Biomarkers metabolism, COVID-19 immunology, Lung pathology, Lymphocytes immunology, Pneumonia, Viral immunology, Receptors, CCR10 metabolism, SARS-CoV-2 physiology
- Abstract
Accelerate lung repair in SARS-CoV-2 pneumonia is essential for pandemic handling. Innate lymphoid cells (ILCs) are likely players, given their role in mucosal protection and tissue homeostasis. We studied ILC subpopulations at two time points in a cohort of patients admitted in the hospital due to SARS-CoV-2 infection. COVID-19 patients with moderate/severe respiratory failure featured profound depletion of circulating ILCs at hospital admission, in agreement with overall lymphocyte depletion. However, ILCs recovered in direct correlation with lung function improvement as measured by oxygenation index and in negative association with inflammatory and lung/endothelial damage markers like RAGE. While both ILC1 and ILC2 expanded, ILC2 showed the most striking phenotype changes, with CCR10 upregulation in strong correlation with these parameters. Overall, CCR10
+ ILC2 emerge as relevant contributors to SARS-CoV-2 pneumonia recovery., (© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.)- Published
- 2021
- Full Text
- View/download PDF